StonvexLoading…
StonvexStonvexStonvexCore line items from LTRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $89.75M | $59.57M | $29.79M | $122.92M |
Operating Income | $-3.73M | $-2.60M | $-1.53M | $-11.00M |
Net Income | $-3.91M | $-2.73M | $-1.40M | $-11.37M |
EPS (Diluted) | $-0.10 | $-0.07 | $-0.04 | $-0.29 |
Total Assets | $120.02M | $121.73M | $119.57M | $123.72M |
Total Liabilities | $45.55M | $47.31M | $45.12M | $49.34M |
Cash & Equivalents | $23.52M | $22.96M | $22.19M | $20.10M |
Free Cash Flow OCF − CapEx | $7.55M | $5.62M | $3.53M | $6.78M |
Shares Outstanding | 39.47M | 39.34M | 39.19M | 39.10M |